About Atopia Therapeutics SA
Atopia Therapeutics SA is a Limited based in Genève, in the canton of Geneva, founded in 2016. Its identification number UID is CHE-346.109.235. It is active in "research and experimental development on biotechnology". Currently, the people holding decision-making roles are Jeffrey Shaw (President), Jacques Billy (Member of the board of directors), and Grégoire Chevalier (Member of the board of directors).
Purpose fr de translation
le développement de molécules dans le domaine du traitement de l'asthme et autres maladies allergiques ou inflammatoires; détention, administration et gestion de participation dans des sociétés en Suisse et à l'étranger à l'exception des opérations prohibées par la LFAIE (cf. statuts pour but complet).
Date of registration
23/05/2016 (about 10 years)
UID
CHE-346.109.235
Branches
Genève Headquarter
Related companies or same address
Address
Chemin des Mines 15
1202 Genève
Phone numbers
Decision-maker contacts
Personal contacts
-
Jeffrey Shaw
From Italie, in VeyrierPresident
Joint signature at 2
From: 2020-01-24 (Joined on 2016-06-08)
To: present
-
Grégoire Chevalier
From France, in Paris, FRAMember of the board of directors
Joint signature at 2
From: 2024-06-17
To: present
